Your browser doesn't support javascript.
loading
Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indications.
Krebs, M G; Blay, J-Y; Le Tourneau, C; Hong, D; Veronese, L; Antoniou, M; Bennett, I.
Afiliação
  • Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: matthew.krebs@manchester.ac.uk.
  • Blay JY; Centre Léon Bérard, UNICANCER, Université Claude Bernard Lyon, Lyon, France.
  • Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris & Saint-Cloud, France.
  • Hong D; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Veronese L; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Antoniou M; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Bennett I; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
ESMO Open ; 6(2): 100072, 2021 04.
Article em En | MEDLINE | ID: mdl-33676294
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article